Target intelligence / Profile preview

Cutibacterium acnes 30S ribosomal subunit (C. acnes 30S subunit)

Target
C. acnes 30S subunit
Molecular classification
Ribosomal subunit, Ribonucleoprotein complex
01

Overview

The 30S ribosomal subunit of Cutibacterium acnes (formerly Propionibacterium acnes) is a fundamental component of the bacterial translation apparatus, responsible for decoding genetic information from messenger RNA. It consists of the 16S ribosomal RNA and approximately 21 ribosomal proteins, which together coordinate the binding of transfer RNA and the initiation of protein synthesis. This subunit is a major pharmacological target for antibiotics used in the treatment of acne vulgaris, such as tetracyclines and aminoglycosides. These drugs typically bind to the decoding center of the 30S subunit, preventing the attachment of aminoacyl-tRNA and thereby halting bacterial growth. While C. acnes is a common skin commensal, its overproliferation and biofilm formation are central to the pathogenesis of inflammatory acne and various opportunistic infections. Recent structural studies have identified C. acnes-specific features of the 30S subunit, such as the presence of the bS22 protein, which may influence drug binding and selectivity. Sarecycline, a narrow-spectrum antibiotic, specifically targets this subunit with high affinity, offering a more selective approach compared to broad-spectrum tetracyclines. Therapeutic intervention targeting the 30S subunit must balance efficacy against the pathogen with the preservation of the host's commensal microbiome and the prevention of antibiotic resistance.

Other names
Propionibacterium acnes 30S ribosomal subunitSmall ribosomal subunit of Cutibacterium acnesC. acnes 30S ribosomal subunit30S ribosomal subunit (Cutibacterium acnes)
02

Mechanism of action

Inhibition of bacterial protein synthesis by binding to the 30S ribosomal subunit, specifically at the decoding center (A-site), which prevents the association of aminoacyl-tRNA with the mRNA-ribosome complex and halts the elongation of the polypeptide chain.

03

Biological functions

Protein synthesisTranslationmRNA decodingtRNA bindingTranslation initiation
04

Disease associations

Acne vulgarisInfectionSarcoidosisProstate cancerEndophthalmitisBlepharitisImplant-associated infection
05

Safety considerations

Antibiotic resistance (e.g., 16S rRNA mutations)Microbiome dysbiosisSkin irritationGastrointestinal distressPhotosensitivity
06

Interacting drugs

Sarecycline

7 more in the full profile.

07

Biomarkers

16S ribosomal RNA sequenceRibosomal subunit proteins (e.g., S15, S18)Phylotype-specific ribosomal protein profilesMALDI-MS prototyping

Beyond the preview

Go deeper on Cutibacterium acnes 30S ribosomal subunit (C. acnes 30S subunit).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cutibacterium acnes 30S ribosomal subunit (C. acnes 30S subunit).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call